80
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia

, , , , , , , , , , , & show all
Pages 800-807 | Received 10 Jul 2023, Accepted 21 Feb 2024, Published online: 03 Mar 2024

References

  • Rowe JM. Perspectives on current survival and new developments in AML. Best Pract Res Clin Haematol. 2021;34(1):101248. doi:10.1016/j.beha.2021.101248
  • Dombret H, Gardin C. An update of current treatments for adult acute myeloid leukemia. Blood. 2016;127(1):53–61. doi:10.1182/blood-2015-08-604520
  • Klco JM, Miller CA, Griffith M, et al. Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia. JAMA. 2015;314(8):811–822. doi:10.1001/jama.2015.9643
  • Ravandi F, Cortes J, Faderl S, et al. Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy. Blood. 2010;116(26):5818–5823; quiz 6153. doi:10.1182/blood-2010-07-296392
  • Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–1377. doi:10.1182/blood.2022016867
  • Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program. 2009;2009(1):385–395. doi:10.1182/asheducation-2009.1.385
  • Khoury JD, Solary E, Abla O, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719. doi:10.1038/s41375-022-01613-1
  • Liersch R, Müller-Tidow C, Berdel WE, et al. Prognostic factors for acute myeloid leukaemia in adults – biological significance and clinical use. Br J Haematol. 2014;165(1):17–38. doi:10.1111/bjh.12750
  • Samra B, Richard-Carpentier G, Kadia TM, et al. Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype. Blood Cancer J. 2020;10(5):47. doi:10.1038/s41408-020-0316-3
  • Han HS, Rybicki LA, Thiel K, et al. White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia. Leuk Lymphoma. 2007;48(8):1561–1568. doi:10.1080/10428190701474373
  • Marras T, Dettori M, Caocci G, et al. White blood cell count nadir and duration of aplasia do not associate with treatment outcome in adult patients with acute myeloid leukemia undergoing intensive chemotherapy. Chemotherapy. 2020;65(3-4):110–114. doi:10.1159/000509816
  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447. doi:10.1182/blood-2016-08-733196
  • Wang Y, Probin V, Zhou D. Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy. Curr Cancer Ther Rev. 2006;2(3):271–279. doi:10.2174/157339406777934717
  • Zhang Y, Dai K, Zhang Q, et al. Normal absolute monocyte count in combination with normal/high absolute lymphocyte count at the time of relapse is associated with improved survival in patients with early relapsed acute myeloid leukemia. Cancer Invest. 2021;39(6–7):550–558. doi:10.1080/07357907.2021.1933013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.